Oivi is preventing blindness among diabetes patients by deploying an AI camera for the automated diagnosis of retinal diseases. We are an ambitious and young medtech company developing a technology to overcome a huge challenge that impacts the lives of millions of people with diabetes. Our vision is to bring to market a low-cost artificial intelligence-enabled retinal camera and automated diagnostics platform for the early screening of Diabetic Retinopathy. We are an experienced team based in Norway and India, trying to achieve what nobody has done so far and we are trying to get there with high speed. Want to join us?

We are foodies that aim to change the chocolate and dessert space. A plant-based, sustainable, and socially responsible product series that most people like does not exist, and we want to change this with VGAN.Our goal is to make the world a slightly better place one bite at a time. VGAN is a small Norwegian company. We have developed å high-quality chocolate with acceptance in the market. VGAN– our lifestyle chocolate is to enjoy with a clear conscience It is better for the environment It is better for your health It is made sustainable The VGAN brand is already registered and protected for all snacking categories in the US and the EU The chocolate is organic, fair trade, gluten-free, soy-free, certified kosher, and of course none GMO.

Drifti is a b2b saas that aims to give back control to the people who work at all levels in the construction industry. Drifti does this by centralizing all administration to one place and by working for you, not by you. That means more productivity in all parts of the value chain. Drifti is growing quickly in Norway where we now work mainly with plumbers and other craftspeople. We are looking to grow our service and team in Oslo, Norway.

At Navidium sustainability is our Number 1 Value. The maritime industry needs to change to be feasible in the future as a global transport mechanism. We believe at Navidium we're building part of the puzzle to solve this problem by using exciting data-driven products that open up a world of interoperable possibilities and we're excited to be driving this change forward with our customers and partners. If you're excited by any of the following then make sure you get in touch- Blue Economy- Software Development (Kafka, k8s, .net, timeserie, MQTT, microservices)- Front End Development (Mainly React)- Maritime Industry- Data Science (Physics and ML based hybrid modeling)- Data Engineering- Voyage Optimisation- Performance Monitoring- Environmental Reporting

We help businesses to grow and succeed with digital marketing through all channels. This includes marketing in search, and social media like Facebook, Instagram, Snapchat, LinkedIn, and more. With data and analysis as a foundation, we set up strategies and execute them. 🌱 Want to know how digital marketing can create value for your business? 🔎 Advertising | Social Media | Search Engine Marketing | Content Creation 💙 We share useful tips and tricks 🚀 Increase your digital presence with us!

We believe that live esports should be available to everyone, in a way that makes it easy to follow and easy to understand. Our goal is to make it available anytime, anywhere, and to unify it all in one place. That’s why we’re building a platform that will revolutionize the way you consume live esports.

Gain visibility and control over your compliance processes with ease! Our integrated GDPR solution includes consent management, data discovery, documentation, audit logs, assessments, people and customer profiles, and much more. We give you a practical approach to GDPR and "Privacy by design". Get also an award-winning access portal that supports secure Single Sign-On access of data and easy setup of security policies. Mesier, The holistic approach to Cloud governance! Currently, we are 10 highly motivated people with extensive experience in making successful software. Let's talk!

Compose Software AS: Redefining Low-code through compliance Compose Software AS is a Norway-based pioneer in low-code and no-code solutions, dedicated to empowering organizations with flexible, compliance-ready platforms. Serving high-security and regulated sectors such as public institutions, legal firms, and healthcare providers, Compose delivers cutting-edge technology tailored to streamline workflows, enhance collaboration, and ensure robust governance. Product Portfolio Compose Enterprise: The Foundation for Scalable Workflow Automation Compose Enterprise is the backbone of Compose's offerings, designed to enable organizations to: Automate Complex Processes: Create and manage intricate workflows with ease, reducing operational bottlenecks. Ensure Compliance: Meet industry-specific regulations with built-in compliance features, including granular access controls. Enable Modular Integration: Seamlessly integrate with existing systems and tools for a unified operational ecosystem. Compose Case Management: Simplifying complex Case Handling at Scale Compose CCM is tailored for organizations managing high volumes of cases, offering: Dynamic Case Handling: Adapt workflows to real-time changes, ensuring efficient processing. Secure Collaboration: Share case details securely across teams with advanced role-based access. Insights and Reporting: Leverage data analytics for actionable insights and compliance audits. Compose Glow: A New Era in Governance and Innovation The newest addition to the Compose family, Glow combines governance with innovation: Streamlined Governance: Enable teams to innovate while adhering to strict compliance requirements. Citizen Developer Enablement: Empower non-technical users to create solutions, fostering cross-functional collaboration. Compose's platforms share the following powerful capabilities: Low-Code Development: Simplify development with visual drag-and-drop interfaces, reducing time to market. Regulatory Compliance: Ensure adherence to GDPR, HIPAA, and other regulatory frameworks. Advanced Workflow Automation: Automate repetitive tasks and optimize complex processes effortlessly. Granular Access Controls: Protect sensitive information with customizable user permissions. Data Integration: Connect seamlessly with APIs, CRMs, and ERPs for a centralized data ecosystem. Compliance-First Design: Trusted by organizations in high-compliance sectors for its robust regulatory adherence. Scalability and Flexibility: Tailored solutions that grow with your organization, from small teams to enterprise-scale operations. Efficiency and ROI: Dramatically reduce operational costs while boosting productivity and innovation. High-Security Standards: Designed for environments where security is non-negotiable, with encryption and access control at its core. Future-Proof Technology: Built with a forward-thinking approach, ensuring compatibility with emerging technologies and trends. Compose Software AS is transforming how organizations approach automation, enabling them to focus on what matters most: innovation and growth.

We have developed a system for calculating and supplying Solcelle, and wind power for Scandinavia. In addition to this, we have obtained a license as a power supplier, so we can offer our customers both purchases and sales of green power. Why solar cells? Sun provides energy. As an energy source, the sun is unsurpassed. Every year, the earth receives 15,000 times more energy from the sun than the earth's population uses. Even in Norway, the sun provides 1,500 times more energy than what we use. Depending on where on the globe you are, the sun provides an amount of energy from 700 to over 2,200 kWh/m2 per year.

Oncoinvent AS is a privately held Norwegian company established in 2010. The company is committed to developing new innovative products to provide better treatment options to cancer patients. The innovations being developed by Oncoinvent AS are a result of the extensive experience with the development of radionuclide-based cancer treatments of two of the founders, Dr. Roy H. Larsen and Professor of clinical oncology Øyvind S. Bruland. Larsen and Bruland are the inventors of the first FDA and EMA-approved alpha-emitting pharmaceutical product Xofigo® (Bayer AG), as well as of the beta-emitting radio-immunotherapeutic product candidate Betalutin® (Nordic Nanovector ASA). Oncoinvent's lead product candidate, Radspherin®, is a novel alpha-emitting radioactive microsphere designed for the treatment of metastatic cancers in body cavities. Radspherin® has been shown to cause a significant reduction in tumor cell growth. It is anticipated that the product can potentially treat several forms of metastatic cancer. The first clinical indication for Radspherin® will be the treatment of peritoneal carcinomatosis. Clinical development will be conducted in collaboration with European and American clinical research centers.

Garden is a development automation platform for Kubernetes and cloud native applications. The widespread adoption of cloud native technologies such as containers and Kubernetes has made it easier than ever to operate and scale applications. But important developer workflows have been overlooked or neglected along the way. Many developers find that they’re now less productive than they were before the cloud native era. Developers working on distributed microservices applications have been left without an efficient way to build, run tests, and iterate in a production-like environment. Garden makes it easy to spin up production-like environments for development, testing, and CI, and to use the same workflows for every stage of the process. With Garden, developers get fast feedback exactly when they need it, and DevOps teams are no longer bogged down with provisioning and managing ad hoc environments.

At Akusis we deliver relevant content to the more than 1 million people suffering from hypertension. At the same time, we facilitate an easy to use blood pressure measurement proces, that enables general practitioners to receive patient reported data with a significant higher data integrity than the excisting solutions. An ease of mind solution for both patients and doctors, that saves and improves lives, and lowers the expenses in the Danish healthcare system. Hypertension is serious, and when not treated it could be fatal. However, the impact can be reduced, if treated properly and at an early stage. We have talked to a number of both patients and doctors, and from this we learned: * Doctors require more than 500.000 measurements a year. Measurements are performed by the patients in their own home, and self-reported into an existing digital solution. * Measuring and entering data in the system can be difficult, and leads to mistakes in about 36% of the total measurements performed. This gives doctors a poor chance of diagnosing correctly. * There is a need of a more simple and intuitive system, that can reduce the number of bad measurements. * Furthermore, the patients report, that they need information on exactly what hypertension is, and what they can do themselves to lower their blood pressure levels (besides taking their medicine). * Patients feel left alone with a lot of questions, and no one to answer them. Instead they go online, and find the answers in various places, and too often answers that ends up worsening their condition. Our solution is based on our own website, and our mobile application. On both platforms we deliver the content that we know the patients need. Today it is scattered all over, and of mixed quality. We bring it all to a single place. On top of that, we add tailored treatment courses, and hand on tools to be implemented in an every day life, giving the patients a chance to act and improve. Our content is delivered by experts in the areas of sleep, exercise and nutrition, as we know that is what the patients ask for. For those that want more than just information, we deliver access to an easy to use measurement proces, by using the equipment already at hand. Historical readings can be seen on the application, notes can be taken, and it is even possible to send the data to the doctor. The combination of the above signigicantly reduces the impact of hypertension in Denmark, and represents an approach to this specific disease, that doesn´t exist today. The idea for this specific project comes from a member of the founder team, Kurt Rasmussen, and is further developed by the other team members, who are both health tech engineers. Kurt is a general practioner with more than 25 years of experience, and has for (too) long experienced issues related to poor quality of blood pressure measurements, and patients that want to do more, but don´t know how to. We strongly, both as general practitioner and health tech engineers want to improve the every day life of patients, and enabling them to life longer, fuller and richer lives, free from worries and not needed complications. By developing Akusis BPM System, we are able to do so, and at the same time reduce the costs of treating hypertensive patients in DK. We claim, that when fully implemented, we are able to reduce the costs in the amount of billions - even conservatively put around 2-3 of them every year.

PROCUREMENT IS COMPLEX – SO WHY MAKE IT HARDER? Our mission is simple and straightforward. We want to rework procurement and B2B payments – and really make it work. By introducing smarter software, we help procurement and finance professionals cut the tail in long-tail procurement. And in turn, cut the expenditure that follows with traditional indirect spend. Mazepay is founded on a belief that the way large enterprises approach indirect procurement can be significantly improved. It is our goal to assist companies in building a sustainable business, where procurement is seen as a business enhancer that drives efficiency, facilitates growth and ensures financial stability. Mazepay is taken to market together with leading European banks and Mastercard. We bring innovative technology to enable seamless B2B payments for indirect purchasing for both buyers and suppliers. Mazepay is headquartered in Aarhus, Denmark with offices in Copenhagen, Denmark and Novi Sad, Serbia. People and culture: Our people and our culture are important to us and what makes working at Mazepay special. We invest in the team and we celebrate our successes together. Outside of work, we have fun through company events such as Friday drinks, dinners, hiking, go-kart, game nights, outdoor trips, etc.

BetterLabs revolutioner adgangen til sundhedsdata for private ved at give adgang til blodprøver der tidligere var forbeholdt praktiserende læger og hospitaler. Vi samarbejder med næsten 70 prøvesteder, og dækker dermed hele Danmark. De mest solgte prøver er stofskifte test, testosteron test og dybdegående sundhedstjek. Vi skabte BetterLabs da vi selv manglede bedre adgang til blodprøver til brug for sundhedsoptimering og fysisk performance.

Our mission is to revolutionize blood volume measurement and improve treatments for major diseases such as heart failure and kidney diseases. Being successful, we want to lower the cost of health care and save lives doing so. We develop, sell and market devices that measure​ blood volume, plasma volume and red blood cell volume in humans. Our non-medical version addresses the needs of high-performance athletes. Our medical version is under development and its intended to help medical doctors in their decision making on treatments for heart failure, kidney diseases, and cancer.